PENGARUH PEMBERIAN GEL POLIPEPTIDA TOPIKAL TERHADAP PERUBAHAN UKURAN ULKUS DIABETIKUM
1. Background | |
---|---|
Registration Number | INA-2Y49T46A |
Date of registry approval | 04-08-2025 |
Registration Date | 03-08-2025 |
Secondary identifiers | No |
Name of issuing authority (for example protocol number, other registries, etc) | |
Secondary identifier number | |
Scientific study title | PENGARUH PEMBERIAN GEL POLIPEPTIDA TOPIKAL TERHADAP PERUBAHAN UKURAN ULKUS DIABETIKUM |
Public (popular study title) | PENGARUH PEMBERIAN GEL POLIPEPTIDA TOPIKAL TERHADAP PERUBAHAN UKURAN ULKUS DIABETIKUM |
2. Sponsor and Funding | |
Primary Sponsor | The main researcher is the individual sponsor of the study |
Source(s) of monetary or material support | Dermatology and Venereology Department of Sebelas Maret University/ Dr. Moewardi General Hospital, Surakarta |
Other partners | Not Specified |
3. Contact details | |
Principal Investigator | |
Principal investigator | Dr. dr. Suci widhiati, M.Sc., Sp.DVE, Subsp. DA |
City | Surakarta |
Country | Indonesia |
Principal investigator's affiliation | Dermatology and Venereology Department of Sebelas Maret University/ Dr. Moewardi General Hospital, Surakarta |
Principal Investigator's email address | suci_riza@yahoo.com |
Public Queries | |
Contact person name for public queries | dr. Stella Gracia Octarica |
Address for public queries | Department of Dermatology and Venereology, Dr. Moewardi General Hospital, Jl. Kolonel Sutarto No.132, Jebres, Kec. Jebres, Kota Surakarta, Jawa Tengah 57126 |
City | Surakarta |
Country | Indonesia |
ZIP | 57126 |
Affiliation for public queries | Dermatology and Venereology Department of Sebelas Maret University/ Dr. Moewardi General Hospital, Surakarta |
Email address for public queries | stellagracia_o@yahoo.com |
Phone number for public queries | +6281392771790 |
Scientific Queries | |
Name of Contact for scientific queries | dr. Stella Gracia Octarica |
Address for scientific queries | Department of Dermatology and Venereology, Dr. Moewardi General Hospital, Jl. Kolonel Sutarto No.132, Jebres, Kec. Jebres, Kota Surakarta, Jawa Tengah 57126 |
City | Surakarta |
Country | Indonesia |
ZIP | 57126 |
Affiliation of scientific queries contact | Dermatology and Venereology Department of Sebelas Maret University/ Dr. Moewardi General Hospital, Surakarta |
Email address for scientific queries | stellagracia_o@yahoo.com |
4. IRB & Regulatory | |
Ethical Approval number | 1.920 /VI/ HREC /2024 |
Name of Ethics committee | Komite Etik Penelitian Kesehatan RSUD Dr. Moewardi |
Date of Ethic approval | 06-08-2024 |
Contact details of Ethic Committee (phone, email, and office) | Komite Etik Penelitian Kesehatan RSUD Dr. Moewardi (0271) 634634 ext 525 085647160979 |
Number of Persetujuan Pelaksanaan Uji Klinik (PPUK)/Persetujuan Protokol Uji BE (PPUB) | Not applicable |
5. Status | |
Countries of recruitment | Indonesia |
Study sites in Indonesia | Surakarta |
Recruitment status | Initial |
Date of first enrollment | 22-01-2025 |
Targeted Sample size | 00026 - |
Number of enrolled participants | 26 |
Date of study completion (last participant, last visit) | |
6. Study Design & Purpose | |
Primary health condition(s) or problem(s) studied (e.g., depression, breast cancer,medication error) | Diabetic ulcer |
Purpose of the study | Supportive care |
Study type | Interventional |
Interventional Study category | Clinical trial |
Study phase | Phase 1 |
Method of allocation | Randomized allocation |
Description of the allocation concealment mechanism and sequence generation | Pasien di randomisasi dengan tabel randomisasi dan di berikan terapi secara blinding, dibagi menjadi 2 kelompok, kelompok kontrol dan perlakuan, dimana Penelitian juga tidak mengetahui isi dari obat yang diberikan kepada pasien. |
Masking | Pasien dan Peneliti |
Study intervention (study arm) | Pemberian Gel polipeptida 7% secara topikal untuk ulkus diabetikum |
Control intervention (control arm) | Pemberian gel duoderm hydroactive gel |
Intervention assignment | Single arm |
7. Eligibility Criteria | |
Gender inclusion criteria | Not specified |
Minimum age | 18 |
Maximum age | Not Specified |
Inclusion criteria | Pasien berusia >18 tahun
Pasien dengan ulkus diabetikum derajat I-IV |
Exclusion criteria | Pasien yang memiliki alergi terhadap bahan
Pasien yang sudah mendapatkan terapi lain pasien yang menolak mengikuti penelitian |
8. Study Outcome | |
Primary Outcome | |
Name of primary outcome | Perubahan luas permukaan ulkus diabetikum |
Metric/method of measurement | Dokumentasi dengan kamera dan analisa dengan ImageJ |
Timepoint(s) of measurement | Pada Hari kedatangan ke 0, 7, 14, dan hari ke 21 |
9. Study Results | |
Brief summary of study results | |
Date of results summaries | |
Participant flow | |
Baseline characteristic | Usia
Jenis kelamin Indeks massa tubuh Jenis Diabetes Komorbid Derajat Ulkus Bakteri Penyulit Lokasi Ulkus |
Adverse events | |
Outcome measures | |
10. Publication | |
URL hyperlink(s) related to results and publications | |
IPD sharing statement (Statement regarding the intended sharing of deidentified individual clinical trial participant-level data (IPD)) | Undecided |
Plan for IPD sharing (what IPD will be shared, when, by what mechanism, with whom, and for what types of analyses) | |
Other important informations | Not Specified |